The TruScreen Medical Advisory Committee’s role is to advise the directors and executive of TruScreen on clinical, scientific and medical matters. This includes the review of clinical trials, monitoring developments in the screening, diagnosis and treatment of cervical cancer, advising on screening and referral paradigms and patient management protocols.
In addition, the Medical Advisory Committee (MAC) advise on additional applications of the existing TruScreen technology and any other technologies that may be of interest to TruScreen.
The TruScreen Medical Advisory Board is led by Colonel (Dr.) Michael J. Campion.
Dr. Campion is a Senior Staff Specialist and Head of the Pre Invasive Clinic at the Gynaecological Cancer Centre of the Royal Hospital for Women in Sydney and is a Conjoint Associate Professor, School of Women’s and Children’s Health, at the University of New South Wales. He has over 30 years’ experience as a qualified medical practitioner and over 20 years of experience as an expert colposcopist.
In addition, Dr. Campion is the Director, Health Services Army Reserve – Eastern Region for the Royal Australian Army Medical Corps and is both a Board member and National Hospitaller, St John Ambulance, Australia. Dr. Campion has written numerous peer reviewed papers and chapters on cervical cancer, including papers on TruScreen®.
Professor Hacker is Conjoint Professor of Gynaecological Oncology at the University of New South Wales and recently retired from clinical practice after 32 years as the director of the Gynaecological Cancer Centre, Royal Hospital for Women in Sydney, where he continues to serve as an Emeritus consultant.
He is a past President of the Society of Pelvic Surgeons. He is a past President of the International Gynaecological Cancer Society, former Chairman of the Oncology Committee of the RANZCOG, and a former Chairman of Examiners for Gynaecologic Oncology, RANZCOG.